logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Mitrelias, Athanasios, Dr
    Company Director born in March 1969
    Individual (5 offsprings)
    Officer
    icon of calendar 2011-07-15 ~ dissolved
    OF - Director → CIF 0
  • 2
    Tselepi-mitrelias, Marina, Dr
    Company Director born in February 1969
    Individual (2 offsprings)
    Officer
    icon of calendar 2011-07-15 ~ dissolved
    OF - Director → CIF 0
Ceased 2
  • 1
    Lytvynenko, Sergiy, Dr
    Company Director born in November 1959
    Individual
    Officer
    icon of calendar 2011-07-15 ~ 2016-12-28
    OF - Director → CIF 0
  • 2
    Orel, Valerii, Prof
    Company Director born in August 1945
    Individual
    Officer
    icon of calendar 2011-07-15 ~ 2016-12-28
    OF - Director → CIF 0
parent relation
Company in focus

CAVENDISH NANOTHERAPEUTICS LIMITED

Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Par Value of Share
Class 1 ordinary share
0 GBP2015-07-01 ~ 2016-12-31
Tangible fixed assets
27,434 GBP2015-06-30
Debtors
1,004 GBP2016-12-31
1,225 GBP2015-06-30
Cash at bank and in hand
317 GBP2016-12-31
179 GBP2015-06-30
Current Assets
1,321 GBP2016-12-31
1,404 GBP2015-06-30
Current liabilities
156,629 GBP2016-12-31
131,801 GBP2015-06-30
Net Current Assets/Liabilities
-155,308 GBP2016-12-31
-130,397 GBP2015-06-30
Total Assets Less Current Liabilities
-155,308 GBP2016-12-31
-102,963 GBP2015-06-30
Called-up share capital
1,051 GBP2016-12-31
1,051 GBP2015-06-30
Share premium account
2,499 GBP2016-12-31
2,499 GBP2015-06-30
Retained earnings
-158,858 GBP2016-12-31
-106,513 GBP2015-06-30
Shareholder's fund
-155,308 GBP2016-12-31
-102,963 GBP2015-06-30
Cost/valuation of tangible fixed assets
64,195 GBP2015-06-30
Tangible fixed assets - Disposals
-65,653 GBP2015-07-01 ~ 2016-12-31
Depreciation of tangible fixed assets
36,761 GBP2015-06-30
Depreciation expense of tangible fixed assets in the period
28,578 GBP2015-07-01 ~ 2016-12-31
Tangible fixed assets - Decrease/increase in depreciation due to disposals
-65,339 GBP2015-07-01 ~ 2016-12-31
Number of shares allotted
Class 1 ordinary share
105,109 shares2016-12-31
Paid-up share capital
Class 1 ordinary share
1,051 GBP2016-12-31
1,051 GBP2015-06-30
  • CAVENDISH NANOTHERAPEUTICS LIMITED
    Info
    Registered number 07706398
    icon of addressCpc1 Capital Park, Fulbourn, Cambridge, Cambridgeshire CB21 5XE
    PRIVATE LIMITED COMPANY incorporated on 2011-07-15 and dissolved on 2017-06-27 (5 years 11 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.